Improving training on hepatitis B research in Nigeria: Findings from an innovation bootcamp to strengthen capacity
Suzanne Day(University of North Carolina at Chapel Hill), Idris A. Oladosu(University of Ibadan), Sonam Shah(University of North Carolina at Chapel Hill), Abideen Salako, Folahanmi Tomiwa Akinsolu(Nigerian Institute of Medical Research), Peyton Thompson(University of North Carolina at Chapel Hill), Ucheoma Nwaozuru(Wake Forest University), Dan Wu(Shanghai Children's Medical Center), Adesola Zaidat Musa(Nigerian Institute of Medical Research), Olufunto A. Olusanya(Washington University in St. Louis), Olufunmilayo Lesi(University of Lagos), Temitope Ojo(Washington University in St. Louis), Titilola Gbaja‐Biamila(Nigerian Institute of Medical Research), Joseph D. Tucker(University of North Carolina at Chapel Hill), Juliet Iwelunmor(Washington University in St. Louis), Collins O. Airhihenbuwa(Georgia State University), Peter Kalulu, Maria Afadapa(Washington University in St. Louis), Nkiruka Obodoechina, Joseph Ogbeh, Oluwaseun Falade‐Nwulia(Johns Hopkins University), Olaitan H. Olayiwola(University of Ibadan), Kristie L. Foley(Wake Forest University)
Cited by 0
Related Papers
Global burden of primary liver cancer in 2020 and predictions to 2040
|Journal of Hepatology|2022|2.1k
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review
|The Lancet. Gastroenterology & hepatology|2022|244